Beranda › Penyakit Hati Steatotik › California › San Diego
Uji klinis Penyakit Hati Steatotik di San Diego, CA
14 studi untuk Penyakit Hati Steatotik mencari peserta di lokasi sekitar San Diego (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Menerima pesertaFase 3
- 89bio Clinical Study Site, Coronado · 2 mi jauhnya
- 89bio Clinical Study Site, La Jolla · 11 mi jauhnya
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Menerima pesertaFase 3
- 89bio Clinical Study Site, Coronado · 2 mi jauhnya
- 89bio Clinical Study Site, La Jolla · 11 mi jauhnya
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Menerima pesertaFase 2
- Southern California Research Center, Coronado · 2 mi jauhnya
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Menerima pesertaFase 2
- University of California San Diego NAFLD Research Center, La Jolla · 11 mi jauhnya
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Menerima pesertaFase 2
- Southern California Research Center, Coronado · 2 mi jauhnya
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Menerima pesertaFase 3
- Medical Associates Research Group, San Diego
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla · 11 mi jauhnya
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Menerima pesertaFase 3
- Akero Clinical Study Site, Coronado · 2 mi jauhnya
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Menerima pesertaFase 3
- GSK Investigational Site, San Diego
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Menerima pesertaFase 2
- UCSD Medical Center, La Jolla · 11 mi jauhnya
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Menerima pesertaFase 2
- GSK Investigational Site, Coronado · 2 mi jauhnya
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Menerima pesertaFase 3
- GSK Investigational Site, San Diego
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Menerima pesertaStudi observasional
- University of California San Diego, La Jolla · 11 mi jauhnya
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
Menerima pesertaStudi observasional
- University of California San Diego, La Jolla · 11 mi jauhnya
Implementing Food Referrals for Equity and Sustained Health
Menerima pesertaFase 2Sukarelawan sehat diterima
- Rady Children's Hospital San Diego, San Diego
Uji klinis Penyakit Hati Steatotik di kota lain
- San Antonio, TX17 studi
- New York City, NY16 studi
- Miami, FL16 studi
- Houston, TX13 studi
- Austin, TX13 studi
- Richmond, VA12 studi
- Tucson, AZ10 studi
- Chandler, AZ10 studi
- Orlando, FL9 studi
- Dallas, TX9 studi
- St. Louis, MO9 studi
- Hialeah, FL9 studi
Studi lain di San Diego
- Kanker Paru Non-Sel Kecil48 studi
- Kanker Payudara42 studi
- Kanker (semua jenis)32 studi
- Kanker Prostat31 studi
- Kanker Metastatik30 studi
- Kanker Kolorektal25 studi
- Kanker Ovarium24 studi
- Kanker Pankreas24 studi
- Gagal Jantung23 studi
- Obesitas23 studi
- Kanker Paru23 studi
- Depresi21 studi
Dari ClinicalTrials.gov, data diambil 7 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.